TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,498 | -48.5% | 78,050 | +52.9% | 0.00% | -66.7% |
| Q2 2023 | $1,268,082 | +65.2% | 51,050 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $767,792 | +97.9% | 51,050 | -22.2% | 0.00% | +100.0% |
| Q3 2022 | $388,000 | -21.0% | 65,580 | -43.2% | 0.00% | 0.0% |
| Q2 2022 | $491,000 | +63.7% | 115,430 | +265.9% | 0.00% | 0.0% |
| Q1 2022 | $300,000 | -49.9% | 31,550 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $599,000 | -64.7% | 31,550 | -27.8% | 0.00% | -66.7% |
| Q2 2021 | $1,695,000 | -19.5% | 43,703 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $2,106,000 | -41.6% | 43,703 | -36.9% | 0.01% | -37.5% |
| Q4 2020 | $3,605,000 | +97.2% | 69,309 | +1.5% | 0.01% | +60.0% |
| Q3 2020 | $1,828,000 | – | 68,309 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |